Overview

Ramipril 10 mg/Day Prevention

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

The objective is to investigate the safety of ramipril 10 mg/day used in prevention of cardiovascular events in high-risk patients, including the criteria of the HOPE study.

Phase:

Phase 4

Details

Lead Sponsor:

Sanofi

Treatments:

Ramipril